<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:amplify="http://amplify.com/xmlns/amplify"
>

<channel>
	<title>edrneelesh</title>
	<atom:link href="http://edrneelesh.amplify.com/feed" rel="self" type="application/rss+xml" />
	<link>http://edrneelesh.amplify.com</link>
	<description>Things I Amplify from the web</description>
	<pubDate>Thu, 18 Mar 2010 05:42:50 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
	<language>en</language>
			<item>
		<title>Using Slideshare for B2B lead generation</title>
		<link>http://edrneelesh.amplify.com/2010/03/18/using-slideshare-for-b2b-lead-generation/</link>
		<comments>http://edrneelesh.amplify.com/2010/03/18/using-slideshare-for-b2b-lead-generation/#comments</comments>
		<pubDate>Thu, 18 Mar 2010 05:42:42 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[ceo rashmi sinha]]></category>

		<category><![CDATA[generate leads]]></category>

		<category><![CDATA[pre-dominant]]></category>

		<category><![CDATA[slideshare]]></category>

		<category><![CDATA[surprise]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/03/18/using-slideshare-for-b2b-lead-generation/</guid>
		<description><![CDATA[Clipped from www.socialmediatoday.comIt will probably come as no surprise that the pre-dominant activity on SlideShare, according to the company&#8217;s CEO Rashmi Sinha, who I spoke with recently about the launch of their new branded channels, is B2B lead generation.
    
    B2B sales cycles exceed those of B2C, because the [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: D49B9F11-918E-4798-A6E1-A7955DFCC9F6 CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.socialmediatoday.com/SMC/182419" href="http://www.socialmediatoday.com/SMC/182419">www.socialmediatoday.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.socialmediatoday.com/SMC/182419"><table cellpadding="0" cellspacing="0"><tr><td>It will probably come as no surprise that the pre-dominant activity on SlideShare, according to the company&#8217;s CEO Rashmi Sinha, who I spoke with recently about the launch of their <a rel="nofollow" href="http://www.slideshare.net/channels">new branded channels</a>, is B2B lead generation.<br />
    <br />
    B2B sales cycles exceed those of B2C, because the former requires someone be walked through a process, learn best practices and see relevant case studies to arrive at a purchasing decision. And currently, PowerPoint presentations are the popular media used in business to get that done.<br />
    <span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.socialmediatoday.com/SMC/182419" href="http://www.socialmediatoday.com/SMC/182419">Read more at www.socialmediatoday.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/03/18/using-slideshare-for-b2b-lead-generation/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.socialmediatoday.com/SMC/182419</amplify:clipsource>
<amplify:clipsourceshort>www.socialmediatoday.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>The Hindu Business Line : Drug firms worried over Medical Council&#8217;s ethics code</title>
		<link>http://edrneelesh.amplify.com/2010/03/16/the-hindu-business-line-drug-firms-worried-over-medical-councils-ethics-code/</link>
		<comments>http://edrneelesh.amplify.com/2010/03/16/the-hindu-business-line-drug-firms-worried-over-medical-councils-ethics-code/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 06:51:59 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[business]]></category>

		<category><![CDATA[council]]></category>

		<category><![CDATA[ethics]]></category>

		<category><![CDATA[medical]]></category>

		<category><![CDATA[worried]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/03/16/the-hindu-business-line-drug-firms-worried-over-medical-councils-ethics-code/</guid>
		<description><![CDATA[http://www.thehindubusinessline.com/2010/03/16/stories/2010031&#8230;&#160;&#160;]]></description>
			<content:encoded><![CDATA[<div class="Clog_Content_Outer_Bookmark"><!-- BEGIN_CLOG_CONTENT ID: 2CB1E18F-79ED-4569-9C85-5DB6C1402F63 CLOGS.CLIPMARKS.COM --><div class="Clog_Bookmark_Link"><a rel="clipsource" target="_blank" title="http://www.thehindubusinessline.com/2010/03/16/stories/2010031654350100.htm" href="http://www.thehindubusinessline.com/2010/03/16/stories/2010031654350100.htm">http://www.thehindubusinessline.com/2010/03/16/stories/2010031&#8230;</a></div><div></div><div>&nbsp;</div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/03/16/the-hindu-business-line-drug-firms-worried-over-medical-councils-ethics-code/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.thehindubusinessline.com/2010/03/16/stories/2010031654350100.htm</amplify:clipsource>
<amplify:clipsourceshort>www.thehindubusinessline.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>The Pharma answer to online advts</title>
		<link>http://edrneelesh.amplify.com/2010/03/09/the-pharma-answer-to-online-advts/</link>
		<comments>http://edrneelesh.amplify.com/2010/03/09/the-pharma-answer-to-online-advts/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 04:28:53 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[linking]]></category>

		<category><![CDATA[people]]></category>

		<category><![CDATA[proposed]]></category>

		<category><![CDATA[search]]></category>

		<category><![CDATA[social media]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/03/09/the-pharma-answer-to-online-advts/</guid>
		<description><![CDATA[Clipped from www.mmm-online.comIn response to an FDA call for comment on the use of online media by drug companies, the trade group proposed a paid search format somewhat similar to that proposed by Google. PhRMA&#8217;s format would feature the drug&#8217;s branded and generic name, followed by an &#8220;abbreviated indication or therapeutic category,&#8221; and then, in [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: FD74700A-0A3B-47D2-8704-992BA465ABBC CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.mmm-online.com/phrma-to-ddmac-let-my-people-tweet/article/165373/?DCMP=EMC-MMM_Newsbrief" href="http://www.mmm-online.com/phrma-to-ddmac-let-my-people-tweet/article/165373/?DCMP=EMC-MMM_Newsbrief">www.mmm-online.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.mmm-online.com/phrma-to-ddmac-let-my-people-tweet/article/165373/?DCMP=EMC-MMM_Newsbrief"><table cellpadding="0" cellspacing="0"><tr><td>In response to an FDA call for comment on the use of online media by drug companies, the trade group proposed a paid search format somewhat similar to that proposed by Google. PhRMA&#8217;s format would feature the drug&#8217;s branded and generic name, followed by an &#8220;abbreviated indication or therapeutic category,&#8221; and then, in the left hand corner, an FDA logo reading &#8220;FDA regulated&#8221; that links to risk information, along with a line warning of risks and linking to the patient medication guide. <br /><br />For drugs with boxed warnings, PhRMA suggested, the line might read &#8220;You should be aware of serious risks associated with this product.&#8221; For those without a boxed warning, the line would read &#8220;All drugs have risks. Click here for important safety information.&#8221;<span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.mmm-online.com/phrma-to-ddmac-let-my-people-tweet/article/165373/?DCMP=EMC-MMM_Newsbrief" href="http://www.mmm-online.com/phrma-to-ddmac-let-my-people-tweet/article/165373/?DCMP=EMC-MMM_Newsbrief">Read more at www.mmm-online.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/03/09/the-pharma-answer-to-online-advts/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.mmm-online.com/phrma-to-ddmac-let-my-people-tweet/article/165373/?DCMP=EMC-MMM_Newsbrief</amplify:clipsource>
<amplify:clipsourceshort>www.mmm-online.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>Multipurpose Molecule for Cancer Surgery</title>
		<link>http://edrneelesh.amplify.com/2010/03/08/multipurpose-molecule-for-cancer-surgery/</link>
		<comments>http://edrneelesh.amplify.com/2010/03/08/multipurpose-molecule-for-cancer-surgery/#comments</comments>
		<pubDate>Mon, 08 Mar 2010 07:48:29 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[informatics]]></category>

		<category><![CDATA[cancer]]></category>

		<category><![CDATA[cancer surgery]]></category>

		<category><![CDATA[multipurpose molecule]]></category>

		<category><![CDATA[san diego]]></category>

		<category><![CDATA[technology]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/03/08/multipurpose-molecule-for-cancer-surgery/</guid>
		<description><![CDATA[Clipped from www.technologyreview.comA new molecule designed to seek out and label cancer cells could help guide surgeons to hidden pockets of disease&#8211;a technology that could one day allow for more complete tumor removal and increase a patient&#8217;s chances of survival.
									
										
											
										
										
											
Seeing red: Infrared fluorescent labels, targeted to cancerous tumor cells, provide a luminescent guide for surgeons [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: 6ACA7D6B-5E55-4A4D-A212-B707B7B06A21 CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.technologyreview.com/biomedicine/24667/" href="http://www.technologyreview.com/biomedicine/24667/">www.technologyreview.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.technologyreview.com/biomedicine/24667/"><table cellpadding="0" cellspacing="0"><tr><td><p>A new molecule designed to seek out and label cancer cells could help guide surgeons to hidden pockets of disease&#8211;a technology that could one day allow for more complete tumor removal and increase a patient&#8217;s chances of survival.</p>
									<table width="1" cellspacing="0" cellpadding="0" border="0">
										<tbody><tr>
											<td><img width="220" height="164" border="0" src="http://www.technologyreview.com/files/37763/fig1_x220.jpg" /></td>
										</tr>
										<tr>
											<td>
<b>Seeing red</b>: Infrared fluorescent labels, targeted to cancerous tumor cells, provide a luminescent guide for surgeons trying to remove the lethal tissue. 
												<br />
												Credit: Nguyen et al. PNAS, doi:10.1073/pnas.0910261107

											</td>
										</tr>


									</tbody></table>
<p>The molecular label, developed by researchers at the University of California at San Diego (UCSD), works in two ways. It tags cancer cells with a fluorescent marker to highlight tumors for identification and removal during surgery, and it contains a magnetic marker that can be used to evaluate the disease via magnetic resonance imaging.</p><span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.technologyreview.com/biomedicine/24667/" href="http://www.technologyreview.com/biomedicine/24667/">Read more at www.technologyreview.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/03/08/multipurpose-molecule-for-cancer-surgery/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.technologyreview.com/biomedicine/24667/</amplify:clipsource>
<amplify:clipsourceshort>www.technologyreview.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>Pfizer launches emerging-markets discounts</title>
		<link>http://edrneelesh.amplify.com/2010/02/08/pfizer-launches-emerging-markets-discounts/</link>
		<comments>http://edrneelesh.amplify.com/2010/02/08/pfizer-launches-emerging-markets-discounts/#comments</comments>
		<pubDate>Tue, 09 Feb 2010 04:48:36 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[discounts]]></category>

		<category><![CDATA[emerging-markets]]></category>

		<category><![CDATA[launches]]></category>

		<category><![CDATA[patient]]></category>

		<category><![CDATA[pfizer]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/02/08/pfizer-launches-emerging-markets-discounts/</guid>
		<description><![CDATA[hmmm&#8230;Clipped from www.fiercepharma.comIn a bid to make it easier for emerging-markets customers to buy its drugs, Pfizer has launched an discount-card system that offers price cuts of up to 50 percent. The company is unveiling the program in Russia this month, looking to attract 500,000 patients over the next year or so. And it&#8217;s aiming [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Commentary_Wrap"><div class="Clog_Post_Text"><p>hmmm&#8230;</p></div></div><div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: 1C05AF4B-DD2C-4319-BF10-3A453525BBEF CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal" href="http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal">www.fiercepharma.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal"><table cellpadding="0" cellspacing="0"><tr><td><p><span>In a bid to make it easier for emerging-markets customers to buy its drugs, Pfizer has launched an discount-card system that offers price cuts of up to 50 percent. The company is unveiling the program in Russia this month, looking to attract 500,000 patients over the next year or so. And it&#8217;s aiming for fast-growing card programs in Mexico, Brazil and Venezuela, too.</span></p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal"><table cellpadding="0" cellspacing="0"><tr><td><p>Like the price breaks instituted by other companies in emerging markets&#8211;notably GlaxoSmithKline and Sanofi-Aventis&#8211;the aim of these is to boost the number of scrips in a big way in hopes of making more money by bringing in less from each patient.</p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal"><table cellpadding="0" cellspacing="0"><tr><td>But that&#8217;s not all. By using a discount card to deliver the price cut, Pfizer will be able to collect information on each patient who uses its drugs. If a patient fails to refill a scrip on time, for instance, the company could contact that person with a reminder.<span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal" href="http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal">Read more at www.fiercepharma.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/02/08/pfizer-launches-emerging-markets-discounts/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.fiercepharma.com/story/pfizer-launches-emerging-markets-discounts/2010-02-08?utm_medium=nl&amp;utm_source=internal</amplify:clipsource>
<amplify:clipsourceshort>www.fiercepharma.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>Doctors face Buyers remorse after healthcareIT expenditure.</title>
		<link>http://edrneelesh.amplify.com/2010/02/08/doctors-face-buyers-remorse-after-healthcareit-expenditure/</link>
		<comments>http://edrneelesh.amplify.com/2010/02/08/doctors-face-buyers-remorse-after-healthcareit-expenditure/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 12:02:04 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[article]]></category>

		<category><![CDATA[frustrations]]></category>

		<category><![CDATA[search]]></category>

		<category><![CDATA[software]]></category>

		<category><![CDATA[systems]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/02/08/doctors-face-buyers-remorse-after-healthcareit-expenditure/</guid>
		<description><![CDATA[Like jumping in with your eyes wide shut.Clipped from www.healthcareitnews.comWASHINGTON &#8211; Doctors who have shopped for healthcare software have sometimes come to regret their purchases, according to a new story reported by the Huffington Post Investigative Fund.In her feature, Emma Schwartz finds that physicians are often frustrated with their switch from paper to electronic medical [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Commentary_Wrap"><div class="Clog_Post_Text"><p>Like jumping in with your eyes wide shut.</p></div></div><div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: 6B47F190-AC81-437E-81CB-C0234478C7B5 CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows" href="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows">www.healthcareitnews.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows"><table cellpadding="0" cellspacing="0"><tr><td><p>WASHINGTON &#8211; Doctors who have shopped for healthcare software have sometimes come to regret their purchases, according to <a rel="nofollow" href="http://huffpostfund.org/stories/2010/01/shopping-health-software-some-doctors-get-buyer%E2%80%99s-remorse">a new story</a> reported by the Huffington Post Investigative Fund.</p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows"><table cellpadding="0" cellspacing="0"><tr><td>In her feature, Emma Schwartz finds that physicians are often frustrated with their switch from paper to electronic medical records &#8211; spending hundreds of thousands of dollars on software programs, only to find that the new systems are faulty or ineffective.</td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows"><table cellpadding="0" cellspacing="0"><tr><td><p>Beyond faulty software, Schwartz finds that fast-evolving technologies often complicate things, especially for doctors who are unfamiliar with new and complex systems and who aren&#8217;t well-versed in the proper questions to ask in order to ensure quality purchases.</p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows"><table cellpadding="0" cellspacing="0"><tr><td><p>Meanwhile, with so many new players in the industry, it&#8217;s expected that there will be considerable contraction in the coming years &#8211; and it&#8217;s possible that providers might purchase expensive systems from a company that may go out of business.</p><span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows" href="http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows">Read more at www.healthcareitnews.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/02/08/doctors-face-buyers-remorse-after-healthcareit-expenditure/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.healthcareitnews.com/news/docs-face-frustrations-search-it-article-shows</amplify:clipsource>
<amplify:clipsourceshort>www.healthcareitnews.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>Trends in Social Media use.</title>
		<link>http://edrneelesh.amplify.com/2010/02/05/trends-in-social-media-use/</link>
		<comments>http://edrneelesh.amplify.com/2010/02/05/trends-in-social-media-use/#comments</comments>
		<pubDate>Fri, 05 Feb 2010 11:15:22 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[adults]]></category>

		<category><![CDATA[blogging]]></category>

		<category><![CDATA[facebook]]></category>

		<category><![CDATA[pew internet project]]></category>

		<category><![CDATA[report]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/02/05/trends-in-social-media-use/</guid>
		<description><![CDATA[-
Teens prefer facebook to twitter.
-
Blogging is being seen as a &#8220;matured&#8221; use.
Clipped from www.usatoday.comThe young prefer Facebook to blogging, TwitterA new report paints a picture of how teens and young adults are using social media these days.
Teens are eating up Facebook but are not so keen on Twitter, and they are not blogging as much [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Commentary_Wrap"><div class="Clog_Post_Text"><p>-<br />
Teens prefer facebook to twitter.<br />
-<br />
Blogging is being seen as a &#8220;matured&#8221; use.<br />
</p></div></div><div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: D253AE6A-0CD3-4056-835F-8E6D281CACE2 CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm" href="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm">www.usatoday.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm"><table cellpadding="0" cellspacing="0"><tr><td><span>The young prefer Facebook to blogging, Twitter</span></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm"><table cellpadding="0" cellspacing="0"><tr><td><div>A new report paints a picture of how teens and young adults are using social media these days.</div>
<p>Teens are eating up <a rel="nofollow" href="http://content.usatoday.com/topics/topic/Culture/Computers+and+Internet/Facebook">Facebook</a> but are not so keen on <a rel="nofollow" href="http://content.usatoday.com/topics/topic/Twitter+Inc">Twitter</a>, and they are not blogging as much as they used to, according to the Pew Internet Project&#8217;s report.</p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm"><table cellpadding="0" cellspacing="0"><tr><td><p>The report highlights data gathered from two telephone surveys in September, one that focused on teens ages 12-17 and a second survey of adults 18 and older.</p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm"><table cellpadding="0" cellspacing="0"><tr><td><p>Lenhart says blogging among teens and young adults has plummeted to half what it was in 2006. In that year, 28% of teens ages 12-17 and adults ages 18-29 were bloggers. By the fall of 2009, the numbers had dropped to 14% of teens and 15% of young adults. During the same period, the percentage of online adults over 30 who were bloggers rose from 7% in 2006 to 11% in 2009.</p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm"><table cellpadding="0" cellspacing="0"><tr><td><div align="center" class="Clog_Content_Item_Image"><img src="http://content6.clipmarks.com/clog_clip_cache/amplify.com/D253AE6A-0CD3-4056-835F-8E6D281CACE2/2528CF4E-70F5-4195-9BDD-AF380BA24B97" width="245"></div><span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm" href="http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm">See more at www.usatoday.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/02/05/trends-in-social-media-use/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.usatoday.com/tech/wireless/2010-02-04-teensonline04_ST_N.htm</amplify:clipsource>
<amplify:clipsourceshort>www.usatoday.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>Architecture designs for better health</title>
		<link>http://edrneelesh.amplify.com/2010/02/03/architecture-designs-for-better-health/</link>
		<comments>http://edrneelesh.amplify.com/2010/02/03/architecture-designs-for-better-health/#comments</comments>
		<pubDate>Wed, 03 Feb 2010 12:21:02 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[active design guidelines]]></category>

		<category><![CDATA[department]]></category>

		<category><![CDATA[design]]></category>

		<category><![CDATA[new york city]]></category>

		<category><![CDATA[office]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/02/03/architecture-designs-for-better-health/</guid>
		<description><![CDATA[Clipped from www.nyc.govThe Active Design Guidelines provides architects and urban designers with a manual of strategies for creating healthier buildings, streets and urban spaces, based on the latest academic research and best practices in the field. The Guidelines includes: The Active Design Guidelines was developed through a partnership of the New York City departments of [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: 0D5BB48C-FE6E-4B8F-851E-64D78A77F966 CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.nyc.gov/html/ddc/html/design/active_design.shtml" href="http://www.nyc.gov/html/ddc/html/design/active_design.shtml">www.nyc.gov</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.nyc.gov/html/ddc/html/design/active_design.shtml"><table cellpadding="0" cellspacing="0"><tr><td><div align="center" class="Clog_Content_Item_Image"><img src="http://content7.clipmarks.com/clog_clip_cache/amplify.com/0D5BB48C-FE6E-4B8F-851E-64D78A77F966/22546C01-479C-4E6E-8A1E-8B5E6D8626B1" alt="" width="228"></div></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.nyc.gov/html/ddc/html/design/active_design.shtml"><table cellpadding="0" cellspacing="0"><tr><td><p>The <em>Active Design Guidelines</em> provides architects and urban designers with a manual of strategies for creating healthier buildings, streets and urban spaces, based on the latest academic research and best practices in the field. The <em>Guidelines</em> includes: </p></td></tr></table></blockquote><div class="Clog_Content_Hr"></div><blockquote class="Clog_Content_Item" cite="http://www.nyc.gov/html/ddc/html/design/active_design.shtml"><table cellpadding="0" cellspacing="0"><tr><td><p>The <em>Active Design Guidelines</em> was developed through a partnership of the New York City departments of Design and Construction, Health and Mental Hygiene, Transportation, City Planning and the Office of Management and Budget, working with leading architectural and planning academics, and with assistance from the American Institute of Architects New York Chapter. Other City agencies that contributed to the <em>Guidelines</em> include the Mayor&#8217;s Office for People with Disabilities, Mayor&#8217;s Office of Long-Term Planning and Sustainability,  Department of Buildings, Department of Parks and Recreation, School Construction Authority, Housing Preservation and Development and the Department for the Aging.<br />
            </p><span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.nyc.gov/html/ddc/html/design/active_design.shtml" href="http://www.nyc.gov/html/ddc/html/design/active_design.shtml">Read more at www.nyc.gov</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/02/03/architecture-designs-for-better-health/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.nyc.gov/html/ddc/html/design/active_design.shtml</amplify:clipsource>
<amplify:clipsourceshort>www.nyc.gov</amplify:clipsourceshort>
	</item>
		<item>
		<title>Five drugs to watch out for !</title>
		<link>http://edrneelesh.amplify.com/2010/02/02/five-drugs-to-watch-out-for/</link>
		<comments>http://edrneelesh.amplify.com/2010/02/02/five-drugs-to-watch-out-for/#comments</comments>
		<pubDate>Tue, 02 Feb 2010 11:16:11 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[approval]]></category>

		<category><![CDATA[approved]]></category>

		<category><![CDATA[assuming fda]]></category>

		<category><![CDATA[assuming fda approval]]></category>

		<category><![CDATA[novo nordisk]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/02/02/five-drugs-to-watch-out-for/</guid>
		<description><![CDATA[Clipped from www.pharmalot.comWhich drugs will be worth watching this year? Assuming FDA approvals come through as planned - and handicapping that possibility is trickier than ever (see here) - Barron&#8217;s compiled a list with the help of a few analysts. The presumption is that, once approval occurs, these meds will likely become blockbusters, that old-fashioned [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: 2A504929-BE4D-4B15-8B61-2709C3C52440 CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://www.pharmalot.com/2010/02/five-drugs-to-watch-assuming-fda-approval/" href="http://www.pharmalot.com/2010/02/five-drugs-to-watch-assuming-fda-approval/">www.pharmalot.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://www.pharmalot.com/2010/02/five-drugs-to-watch-assuming-fda-approval/"><table cellpadding="0" cellspacing="0"><tr><td><p>Which drugs will be worth watching this year? Assuming FDA approvals come through as planned - and handicapping that possibility is trickier than ever (<a rel="nofollow" href="http://www.pharmalot.com/2010/01/fda-approval-rate-in-09-about-same-as-08/">see here</a>) - Barron&#8217;s compiled a list with the help of a few analysts. The presumption is that, once approval occurs, these meds will likely become blockbusters, that old-fashioned term for the biggest of sellers. And so, in no particular order, here they are&#8230;</p>
<p><a rel="nofollow" href="http://diabetes.webmd.com/news/20100126/new-diabetes-drug-victoza-approved">Victoza</a> - the recently approved diabetes drug from Novo Nordisk;<br />
<a rel="nofollow" href="http://www.reuters.com/article/idUSLE47151020090714">Xarelto</a>* - a clotbuster from Bayer and Johnson &amp; Johnson;<br />
<a rel="nofollow" href="http://invivoblog.blogspot.com/2009/10/never-mind-delay-amgen-puts-dmab-on-its.html">Prolia</a>* - an osteoporosis treatment from Amgen;<br />
<a rel="nofollow" href="http://www.cnbc.com/id/32757381">Qnexa</a>* - the Vivus obesity pill;<br />
<a rel="nofollow" href="http://www.pharmalot.com/2009/10/dendreon-adds-heavyweights-to-its-board/">Provenge</a>* - Dendreon&#8217;s controversial prostate cancer vaccine.</p>
<p>* - not yet approved by the FDA</p><span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://www.pharmalot.com/2010/02/five-drugs-to-watch-assuming-fda-approval/" href="http://www.pharmalot.com/2010/02/five-drugs-to-watch-assuming-fda-approval/">Read more at www.pharmalot.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/02/02/five-drugs-to-watch-out-for/feed/</wfw:commentRss>
	<amplify:clipsource>http://www.pharmalot.com/2010/02/five-drugs-to-watch-assuming-fda-approval/</amplify:clipsource>
<amplify:clipsourceshort>www.pharmalot.com</amplify:clipsourceshort>
	</item>
		<item>
		<title>Knowing your sexual rights</title>
		<link>http://edrneelesh.amplify.com/2010/02/02/knowing-your-sexual-rights/</link>
		<comments>http://edrneelesh.amplify.com/2010/02/02/knowing-your-sexual-rights/#comments</comments>
		<pubDate>Tue, 02 Feb 2010 11:00:11 +0000</pubDate>
		<dc:creator>Neelesh</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<category><![CDATA[persons]]></category>

		<category><![CDATA[receive]]></category>

		<category><![CDATA[rights]]></category>

		<category><![CDATA[sexual]]></category>

		<category><![CDATA[sexuality]]></category>

		<guid isPermaLink="false">http://edrneelesh.amplify.com/2010/02/02/knowing-your-sexual-rights/</guid>
		<description><![CDATA[Clipped from gino-memoirofaschizo.blogspot.comSexual rights embrace human rights that are already recognised in national laws, international human rights documents and other consensus statements. They include the right of all persons, free of coercion, discrimination and violence, to:&#8226; attain the highest accessible standard of sexual health, including access tosexual and reproductive healthcare services;&#8226; seek, receive and impart [...]]]></description>
			<content:encoded><![CDATA[<div class="Clog_Content_Outer"><!-- BEGIN_CLOG_CONTENT ID: 677600C7-E4D7-4C34-84E1-EE33EE2C5A02 CLOGS.CLIPMARKS.COM --><div class="Clog_Top_Wrap"><div class="Clog_Source_First"><span>Clipped from <a rel="clipsource" target="_blank" title="http://gino-memoirofaschizo.blogspot.com/2010/01/knowing-your-sexual-rights.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+blogspot%2FUSOm+%28MEMOIR+OF+A+SCHIZO%29" href="http://gino-memoirofaschizo.blogspot.com/2010/01/knowing-your-sexual-rights.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+blogspot%2FUSOm+%28MEMOIR+OF+A+SCHIZO%29">gino-memoirofaschizo.blogspot.com</a></span></div></div><div class="Clog_Middle_Wrap"><blockquote class="Clog_Content_Item" cite="http://gino-memoirofaschizo.blogspot.com/2010/01/knowing-your-sexual-rights.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+blogspot%2FUSOm+%28MEMOIR+OF+A+SCHIZO%29"><table cellpadding="0" cellspacing="0"><tr><td>Sexual rights embrace human rights that are already recognised in national laws, international human rights documents and other consensus statements. They include the right of all persons, free of coercion, discrimination and violence, to:<br /><br />&#8226; attain the highest accessible standard of sexual health, including access to<br />sexual and reproductive healthcare services;<br />&#8226; seek, receive and impart information related to sexuality;<br />&#8226; receive sexuality education;<br />&#8226; receive respect for bodily integrity;<br />&#8226; choose their partner;<br />&#8226; decide to be sexually active or not;<br />&#8226; practice consensual sexual relations;<br />&#8226; practice consensual marriage;<br />&#8226; decide whether or not, and when, to have children; and<br />&#8226; pursue a satisfying, safe and pleasurable sexual life.<br /><br />In achieving sexual rights consideration must be given to the responsible exercise of human rights requiring that all persons respect the rights of others WHO, 2002 internet).<a rel="nofollow" href="http://gino-memoirofaschizo.blogspot.com/"></a><span class="Clog_Source_Button"><a rel="clipsource" target="_blank" title="http://gino-memoirofaschizo.blogspot.com/2010/01/knowing-your-sexual-rights.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+blogspot%2FUSOm+%28MEMOIR+OF+A+SCHIZO%29" href="http://gino-memoirofaschizo.blogspot.com/2010/01/knowing-your-sexual-rights.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+blogspot%2FUSOm+%28MEMOIR+OF+A+SCHIZO%29">Read more at gino-memoirofaschizo.blogspot.com</a></span></td></tr></table></blockquote></div><div class="Clog_Bottom_Wrap">&nbsp;</div></div>]]></content:encoded>
			<wfw:commentRss>http://edrneelesh.amplify.com/2010/02/02/knowing-your-sexual-rights/feed/</wfw:commentRss>
	<amplify:clipsource>http://gino-memoirofaschizo.blogspot.com/2010/01/knowing-your-sexual-rights.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+blogspot%2FUSOm+%28MEMOIR+OF+A+SCHIZO%29</amplify:clipsource>
<amplify:clipsourceshort>gino-memoirofaschizo.blogspot.com</amplify:clipsourceshort>
	</item>
	</channel>
</rss>
